Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on ...

Clinical trials are facing a crisis amid growing delays, diminishing success rates and rising costs. Companies across the stakeholder spread are investing in AI to ease some of the longstanding ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

April 10 (Reuters) - The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant ...

The Pentagon’s proposed 2026 fiscal year budget comes in at more than one trillion dollars, and $179 billion of that is just for research, development, testing, and evaluation. That money doesn’t go ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...

Advances in biomedical technology are reshaping how human disease is studied and treated, providing credible alternatives to animal testing Tools such as 3D-bioprinted tissues, organ-on-a-chip systems ...

It is difficult to recall a time when doctors and patients had trouble tracking the presence of glucose and other substances in urine and blood. Lack of sufficient measurement tools made it difficult ...

This year, the Department of Defense was authorized to spend $34 billion more on research and development than it was two years ago and only $18 billion more on procurement of new aircraft and ships.